2006
DOI: 10.1158/1078-0432.ccr-05-1380
|View full text |Cite
|
Sign up to set email alerts
|

DNA Polymerase ζ Accounts for the Reduced Cytotoxicity and Enhanced Mutagenicity of Cisplatin in Human Colon Carcinoma Cells That Have Lost DNA Mismatch Repair

Abstract: The mutagenicity of cis-diamminedichloroplatinum(II) (DDP; cisplatin) and the rate at which resistance develops with repeated exposure to DDP are dependent on mutagenic translesional replication across DDP DNA adducts, mediated in part by DNA polymerase~, and on the integrity of the DNA mismatch repair (MMR) system. The aim of this study was to determine whether disabling Pol~by suppressing expression of its hREV3 subunit in human cancer cells can reduce the mutagenicity of DDP and whether loss of MMR facilita… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

2
36
0
1

Year Published

2006
2006
2017
2017

Publication Types

Select...
10

Relationship

1
9

Authors

Journals

citations
Cited by 42 publications
(39 citation statements)
references
References 35 publications
2
36
0
1
Order By: Relevance
“…Recently therapeutic inhibition of Pol ζ has been proposed for the reduction of mutagenesis in cancer cells [36]. Our results suggest that such inhibition may adversely impact mtDNA.…”
Section: Discussionmentioning
confidence: 52%
“…Recently therapeutic inhibition of Pol ζ has been proposed for the reduction of mutagenesis in cancer cells [36]. Our results suggest that such inhibition may adversely impact mtDNA.…”
Section: Discussionmentioning
confidence: 52%
“…This was later shown to be due to REV3L expression and activity (50), although a direct link between the two phenomena was not described. Additionally, homozygous deletions of REV3L in mice resulted in embryonic lethality due to an inability to repair genetic lesions that occur during the developmental process (84).…”
Section: Discussionmentioning
confidence: 99%
“…Knockdown of REV1 in ovarian cancer cell line 2008 and of REV3L in the colorectal tumor cell line HCT116 using shRNA also was associated with more sensitivity to cisplatin as measured by clonogenic assays, compared to the parental lines. Similarly, these mRNA suppressed cells had diminished spontaneous and cisplatin-induced mutagenesis in the HPRT gene [62,63]. Further, overexpression of REV1 in ovarian tumor lines led to some resistance to cisplatin and increased mutagenic frequency compared to parental lines [64].…”
Section: Consequences Of Rev3l Rev1 and Rev7 Reduction In Human Cellmentioning
confidence: 91%